RNU7-138P

Across TCGA pan-cancer cohorts, RNU7-138P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-138P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU7-138P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-138P expression acts as an unfavorable survival marker.

MESO, COAD, and LUSC are the cancer types where RNU7-138P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	III,IV	0.082	0.414	.007	54	view →
COAD	DFS	Tertile	III,IV	0.005	0.668	<.001	36	view →
LUSC	DFS	Tertile	All	0.464	0.752	.012	21	view →
BRCA	OS	Tertile	II,III,IV	0.735	0.914	.013	18	view →
GBM	DFS	Tertile	All	0.061	0.288	<.001	9	view →
KIRC	OS	Tertile	All	0.598	0.884	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-138P–MESO (DFS)

Open the MESO breakdown →